Worldwide reduction in blindness: making progress?
Heraclitus believed that everything is in fl ux, that change encompasses the natural world and the human condition. History buttresses this notion, and the years since 1990 are no exception. Between then and now the world has witnessed tremendous change: the internet, social media, 9/11, global warming, the collapse of the Soviet Union-the list goes on. Amidst these rivers of change, however, a pessimist might note that one thing has remained fairly constant: the number of blind people worldwide.
The prevalence of blindness, as for that of any disorder, crucially is determined by its defi nition. WHO defi nes blindness as presenting visual acuity (ie, the acuity without glasses at the time of testing) in the better eye of less than 3/60. Previously the WHO defi nition cited the best-corrected visual acuity. The logic behind the change was to capture individuals who are blind or visually impaired because of uncorrected refractive error (ie, correctable with spectacles).
The Global Burden of Disease Study 2010 (GBD) aims to provide robust data about the spatiotemporal distribution of major human diseases, including visual impairment, by age and sex worldwide. In The Lancet Global Health, Rupert Bourne and colleagues, 1 for the Vision Loss Expert Group of the GBD, report the distribution and temporal changes in prevalence of blindness and moderate to severe vision impairment from 1990 to 2010, worldwide. According to the current WHO defi nition, their data from 21 regions showed that 31·8 million people were blind in 1990, and in 2010, 32·4 million were blind.
1-3 Of these, in 1990, 68% (95% uncertainty interval 65-70) were blind from treatable causes, compared with 65% (61-68) in 2010. Leading causes of blindness worldwide did not change between 1990 and 2010: cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%).
But the pessimist would be wrong to believe that nothing had changed. The most common cause of blindness is cataracts, which is an age-related disease. Since 1990, the worldwide population and its median age have increased. Hence, changes in demographics pose challenges for reduction of the prevalence of blindness, as they do for other age-related disorders. The optimist points out that the global age-standardised prevalence of blindness for adults aged 50 years and older decreased from 3·0% (95% CI 2·7-3·4) worldwide in 1990 to 1·9% (1·7-2·2) in 2010. 3 A reduction in the prevalence of blindness caused by infections, particularly trachoma and onchocerciasis, was seen, and was achieved mainly through improved infection control. The proportion of global blindness attributed to uncorrected refractive error did not change, and has remained at around 20% since 1990.
Of interest is that Bourne and colleagues used Bayesian hierarchical modelling to provide credible intervals for prevalence of vision impairment. A similar method was used to provide estimates for the proportion of blindness attributable to various causes. Researchers trained in frequentist statistics will not be familiar with this form of statistical analysis. Bayesian statistics are rarely seen in randomised clinical trials and are virtually unheard of in medical laboratory science. Although it has been argued that the Bayesian omelette cannot be made without breaking Bayesian eggs, a Bayesian approach lends itself to hierarchical models, and is arguably the manner in which clinical medicine and science is conducted in practice.
A substantial proportion of blindness due to uncorrected refractive error is probably related to nuclear cataract, which defocuses as well as obscures vision. The misclassifi cation in epidemiological studies occurs because the WHO protocol for blindness surveys instructs researchers to designate as the principal cause of vision impairment that which is most easily treatable. Hence, cataract-induced refractive error might be recorded as uncorrected refractive error when, in fact, the individual requires surgical intraocularlens implantation rather than glasses. Increased rates of cataract surgery earlier in the disease course (with accurate biometric assessment of intraocular-lens power) would reduce the prevalence of blindness due to cataract, uncorrected refractive error, and angle-closure glaucoma, which would kill three birds with one stone. 4 A shocking discrepancy of up to 50 times diff erence in the prevalence of blindness remains between developed countries and developing regions. In fact, populationbased studies from developed regions rarely report the prevalence based on the WHO defi nition. Extrapolation from available data shows that 0·1-0·2% of adults aged 40 years and older in Australia and the USA are blind according to the WHO defi nition, 5, 6 whereas in central Myanmar the rate is 8·0%. 7 Heraclitus was right, of course, everything is in fl ux. Rates of change diff er and may be frustratingly slow, but those interested in reducing the burden of blindness should be encouraged by the trends reported by Bourne and colleagues.
1 They should not, however, be complacent. Challenges remain and further reductions in the prevalence of blindness will not come easily as the rates of age-related retinal and optic-nerve diseases increase with the ageing population. Nevertheless, a scientifi c approach to programme delivery in collaboration with local health workers will continue to reap rewards. 8 
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